Search filters

V-Labs SA closes a significant "angel" financing round

V-Labs SA (former v-Labs Sàrl) has raised a significant angel investment to further grow its business and bring its innovative Augmented Reality product for surveying and construction works to the market. VISCHER has been...

Resistell Closes Series A Financing Round

Resistell AG has closed a milestone-based CHF 3.5M Series A Financing round led by OCCIDENT. TRUMPF Venture, Alpana Ventures, Zürcher Kantonalbank, HEMEX and seven private investors also back the start-up developing world’s...

ARTIDIS announces CHF 8.8M seed financing round

ARTIDIS AG ("ARTIDIS"), a privately held healthtech company, announced the successful closure of a CHF 8.8M seed financing in two rounds, securing early clinical validation and the next development phase towards market entry in...

ImmunOs Therapeutics AG raises CHF 15M in Series A Financing

ImmunOs Therapeutics AG, a Swiss biotechnology company and leading developer of a next generation innate immunity focused immunotherapy platform for cancer, announced today the closing of a Series A financing of CHF 15 million....

Versantis Closes CHF 16m Series B Financing Round

Versantis, a clinical-stage biotech company developing disruptive therapies for rare liver and pediatric diseases, completed an oversubscribed CHF 16 million Series B financing round. Swisscanto Invest by Zürcher Kantonalbank led...

wefox Group raises USD 125 million in B round

wefox Group, the Berlin-based insurtech firm with headquarter in Zurich has successfully raised USD 125 million for its series B round. The USD 125 million investment is the largest series B round for an insurtech company...

Polyneuron raises CHF 22.5 million in a major Series A financing

Polyneuron Pharmaceuticals AG, a developer of a new class of biodegradable glycopolymers for the treatment of autoimmune diseases, today announced the closing of an oversubscribed CHF22.5 million Series A financing. The round was...

Anaveon closes CHF 35 m Series A financing

Anaveon, an immuno-oncology biotech, has successfully concluded a Series A financing round led by Syncona, a UK Life Sciences fund, and joined by the Novartis Venture Fund. The company was founded with financing from BaseLaunch,...

Azafaros B.V. gets seed funding

Azafaros (www.azafaros.com), a biotech company established in Leiden in the Netherlands, focusing on the development of new therapies in the field of rare metabolic disorders, announced the closing of a seed financing round....

Series A Financing Round of aktiia SA

TransLink Capital, a leading US venture capital fund, has invested as lead investor in the Series A financing round of aktiia SA, Neuchâtel, a Swiss startup active in optical blood pressure monitoring.  VISCHER advised TransLink...

You are currently offline. Some pages or content may fail to load.